A detailed history of Clari Vest Asset Management LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Clari Vest Asset Management LLC holds 96 shares of PCRX stock, worth $1,869. This represents 0.0% of its overall portfolio holdings.

Number of Shares
96
Previous 96 -0.0%
Holding current value
$1,869
Previous $2,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$25.5 - $31.51 $1,555 - $1,922
61 Added 174.29%
96 $2,000
Q1 2023

May 08, 2023

SELL
$35.53 - $43.38 $71 - $86
-2 Reduced 5.41%
35 $1,000
Q2 2022

Aug 12, 2022

SELL
$51.49 - $81.64 $227,431 - $360,603
-4,417 Reduced 99.17%
37 $2,000
Q1 2022

May 04, 2022

SELL
$60.03 - $76.49 $360 - $458
-6 Reduced 0.13%
4,454 $340,000
Q4 2020

Feb 09, 2021

BUY
$50.47 - $66.26 $222,068 - $291,544
4,400 Added 7333.33%
4,460 $267,000
Q2 2020

Aug 12, 2020

BUY
$30.8 - $52.47 $1,848 - $3,148
60 New
60 $3,000

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $892M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Clari Vest Asset Management LLC Portfolio

Follow Clari Vest Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clari Vest Asset Management LLC with notifications on news.